Patent · US Expired

Thrombin receptor antagonists

US7304078B2 · kind B2 · utility

18Cited by

9References

67Claims

0Family size

Assignee

SCHERING CORPORATION · US

Inventors

Samuel Chackalamannil · Califon, US
William J. Greenlee · Teaneck, US
Yuguang Wang · Shanghai, CN
Wenxue Wu · Princeton Junction, US
Enrico Veltri · Princeton, US
Yan Xia · Edison, US

Key dates

Filing date	Apr 14, 2003
Grant date	Dec 4, 2007
Priority date	—
Expiry date	Apr 6, 2024

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Heterocyclic-substituted tricyclics of the formulaor a pharmaceutically acceptable salt thereof, wherein:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.